本页面由Tiger Trade Technology Pte. Ltd.提供服务

Adaptive Biotechnologies Corp

22.60
+0.06000.27%
成交量:77.07万
成交额:1,731.52万
市值:36.11亿
市盈率:-69.46
高:22.99
开:22.72
低:21.93
收:22.54
52周最高:23.15
52周最低:9.96
股本:1.60亿
流通股本:1.26亿
量比:0.43
换手率:0.61%
股息:- -
股息率:- -
每股收益(TTM):-0.3254
每股收益(LYR):-0.3922
净资产收益率:-23.95%
总资产收益率:-5.74%
市净率:16.69
市盈率(LYR):-57.63

数据加载中...

2026/07/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/22

重要事件披露

Form 8-K - Current report
2026/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

重要事件披露

Form 8-K - Current report
2026/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/09

重要事件披露

Form 8-K - Current report
2026/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]